Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 03/31/2020

Month EndAs of 03/31/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) -1.10 1.58 -2.02 13.30 10.34
Fund with Sales Charge (%) (POP) -6.54 -0.32 -3.12 12.66 10.07
Quarter EndAs of 03/31/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) -1.10 1.58 -2.02 13.30 10.34
Fund with Sales Charge (%) (POP) -6.54 -0.32 -3.12 12.66 10.07

After-Tax Average Annual Total Returns [further-information] As of 03/31/2020

Month EndAs of 03/31/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -3.11 0.28 -3.46 11.87
Fund without Sales Charge (%) (NAV) After Shares Sold 1.17 1.18 -1.67 10.85
Fund with Sales Charge (%) (POP) Before Shares Sold -8.45 -1.59 -4.54 11.24
Fund with Sales Charge (%) (POP) After Shares Sold -2.15 -0.27 -2.49 10.28
Quarter EndAs of 03/31/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -3.11 0.28 -3.46 11.87
Fund without Sales Charge (%) (NAV) After Shares Sold 1.17 1.18 -1.67 10.85
Fund with Sales Charge (%) (POP) Before Shares Sold -8.45 -1.59 -4.54 11.24
Fund with Sales Charge (%) (POP) After Shares Sold -2.15 -0.27 -2.49 10.28

Calendar Year Returns

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund without Sales Charge (%) (NAV) 34.84 -15.72 18.80 -17.16 5.50 33.91 68.64 29.35 8.35 17.28
Fund with Sales Charge (%) (POP) 27.43 -20.35 11.97 -21.92 -0.57 26.22 58.95 21.90 2.12 10.54
NASDAQ Biotechnology Index (%) 24.41 -9.32 21.06 -21.68 11.42 34.32 65.97 32.29 12.08 15.25
S&P 500 Index (%) 31.49 -4.38 21.83 11.96 1.38 13.69 32.39 16.00 2.11 15.06

Cumulative Total Returns [further-information] As of 03/31/2020

Month EndAs of 03/31/2020 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -12.44 -12.44 -1.10 4.80 -9.68 248.68 819.27
Fund with Sales Charge (%) (POP) -17.25 -17.25 -6.54 -0.96 -14.65 229.48 768.55
Quarter EndAs of 03/31/2020 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -12.44 -12.44 -1.10 4.80 -9.68 248.68 819.27
Fund with Sales Charge (%) (POP) -17.25 -17.25 -6.54 -0.96 -14.65 229.48 768.55

MODERN PORTFOLIO THEORY (MPT) STATISTICSAs of 03/31/2020 (updated monthly)

3 YR 5 YR 10 YR
Standard Deviation (Fund) 22.78 25.06 23.04
Standard Deviation (NASDAQ Biotechnology Index) 20.76 23.27 21.21
Beta 1.05 1.05 1.05
Sharpe Ratio -0.01 -0.13 0.55
Information Ratio -0.29 -0.14 -0.09
Tracking Error 6.40 5.99 6.11

ADDITIONAL RISK STATISTICSAs of 03/31/2020 (updated monthly)

3 YR 5 YR 10 YR
Beta Bull 1.00 0.95 1.03
Beta Bear 0.91 0.99 1.02
Bull Bear Capture Ratio 0.99 1.04 1.00
Gains/Losses 1.14 1.04 1.62

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 1.04%
Net Expense Ratio [further-information] 1.02%
Max Initial Sales Charge 5.50%
CDSC 1.00%

Volatility Measures [further-information] As of 03/31/2020 Updated Monthly, based on a 3-year period

Beta 1.05
Sharpe Ratio -0.01
Standard Deviation 22.78

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index